Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2002
10/03/2002US20020142983 MUC-1 antagonists and methods of treating immune disorders
10/03/2002US20020142954 Laminin 15 and uses thereof
10/03/2002US20020142944 Treatment of ocular disorders
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020139378 Method for creating a separation of posterior cortical vitreous from the retina of the eye
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441455A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2439431A1 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002CA2436340A1 Histidine-rich glycoprotein
10/03/2002CA2434691A1 Use of propentofylline to control intraocular pressure
10/02/2002EP1245233A1 System for stabilizing lacrimal fluid layer
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244780A2 Dna encoding the human serine protease t
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244670A1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244647A1 Quinazoline derivatives as vegf inhibitors
10/02/2002EP1244643A1 Tryptase inhibitors
10/02/2002EP1244641A1 Thiazolyl amide derivatives
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244614A2 Tryptase inhibitors
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244449A1 Use of ketotifen as ophthalmic agent
10/02/2002EP1244443A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
10/02/2002EP1244441A1 Use of trimebutine for treating pain
10/02/2002EP1244438A1 Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
10/02/2002EP1144459B1 Cross-linked hyaluronic acids and medical uses thereof
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372563A Oxathiepino [6,5-b] dihydropyridines, and related compositions and methods
10/02/2002CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
10/02/2002CN1372559A Naphthyridine derivatives processes for their preparation their use and pharmaceutical compositions comprising them
10/02/2002CN1372556A Heterocyclic compound inhibiting angiogenesis
10/02/2002CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002CN1372474A Methods for preventing or attenuating patthoangiogenic conditions
10/02/2002CN1372471A Treatment of allergic rhinitis
10/01/2002US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002US6458853 Treating dry eye
10/01/2002US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002US6458819 Thiazolium compounds and treatments of disorders associated with protein aging
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458805 Antagonists; especially sodium salts
10/01/2002US6458801 Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458564 Amino acid sequence of the protease; for treating imbalance of desquamation
10/01/2002US6458386 Medicaments based on polymers composed of methacrylamide-modified gelatin
10/01/2002US6458376 Nonaqueous fluorinated drug delivery suspensions
10/01/2002US6458364 Non-splicing variants of gp350/220
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2174550C Suspension of loteprednol etabonate
10/01/2002CA2168113C Therapeutic peptide derivatives
10/01/2002CA2089769C Heterocyclic compounds and their preparation and use
09/2002
09/30/2002CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors
09/27/2002CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/26/2002WO2002074913A2 Nucleic acid-associated proteins
09/26/2002WO2002074806A2 New interferon beta-like molecules
09/26/2002WO2002074773A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
09/26/2002WO2002074772A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
09/26/2002WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074749A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074743A1 Aryl-substituted alicyclic compound and medical composition comprising the same
09/26/2002WO2002074733A2 Tryptase-inhibitors
09/26/2002WO2002074730A1 INHIBITORS OF INTEGRIN αvβ¿6?
09/26/2002WO2002074328A1 Methods of treating respiratory conditions
09/26/2002WO2002074318A1 Il-12 expression controlling agents
09/26/2002WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
09/26/2002WO2002074297A1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
09/26/2002WO2002074230A2 A dna molecule encoding a variant paraoxonase and uses thereof
09/26/2002WO2002074193A2 METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN ss4 (Tss4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
09/26/2002WO2002074056A2 Allosteric adenosine receptor modulators
09/26/2002WO2002060382A3 Novel compounds and uses thereof
09/26/2002WO2002051431A9 Therapeutic and/or preventive agents for diseases due to retinal ischemia
09/26/2002WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/26/2002WO2002032872A8 Nitrogenous aromatic ring compounds
09/26/2002WO2002026277A3 Stabilized hydrogen peroxide solutions
09/26/2002WO2001098332A3 Secreted redox proteins
09/26/2002WO2001091756A3 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
09/26/2002WO2001072695A1 Neovascularization inhibitors
09/26/2002WO2001052847A8 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
09/26/2002WO2001032156A3 Methods for treating fibroproliferative diseases
09/26/2002US20020137903 Sodium dependent glucose transporters found in the intestine and kidney (SGLT2); treating diabetes
09/26/2002US20020137798 Treatment of disorders secondary to organic impairments
09/26/2002US20020137777 Benzothiazole, riluzole, phenylbenzothiazole or lifarizine as blocking agents to limit sodium/calcium exchange in the retinal ganglion cells
09/26/2002US20020137755 Tyrosine kinase inhibitors
09/26/2002US20020137687 Novel compounds that inhibit tryptase activity
09/26/2002US20020137676 Selective treatment of endothelial somatostatin receptors
09/26/2002DE10112771A1 New 3-acylamino-3-phenyl-propionic acid derivatives, are integrin inhibitors useful e.g. for treating thrombosis, cardiac infarction, angina pectoris, tumor diseases, inflammation, osteoporosis or infections
09/26/2002CA2469846A1 New interferon beta-like molecules
09/26/2002CA2444526A1 Metalloproteinase inhibitors
1 ... 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 ... 531